Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05265325 |
| Consolidated Lead Sponsor | Kind Pharmaceuticals |
| Therapeutic Condition Cohort | Gastroenterology, Hepatology, and Renal |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 175 participants (ACTUAL) |
| Registered Start Date | 2023-05-03 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The Second Affiliated Hospital of Chongqing Medical University | Chongqing, China | Open Hospital Dossier -> |
| The First Affiliated Hospital of Xiamen University | Xiamen, China | Open Hospital Dossier -> |
| The First Affiliated Hospital of Henan University of Science and Technology | Luoyang, China | Open Hospital Dossier -> |
| Renmin Hospital of Wuhan University | Wuhan, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.